STUDY ON ELEVATED NON-HDL-C AND ITS ASSOCIATION WITH CORONARY ARTERY STENOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING CORONARY STENT IMPLANTATIONS
Main Article Content
Abstract
Background: Current literature suggests that non-HDL-C cholesterol (non-HDL-C) levels are associated with prognosis in patients with acute coronary syndrome (ACS) undergoing coronary stenting. However, unlike LDL-C, existing studies have shown inconsistent results, particularly in Vietnam. Objectives: To determine the prevalence of elevated serum non-HDL-C levels and the association with coronary artery stenosis in ACS patients undergoing coronary stenting. Materials and methods: A cross-sectional descriptive study was conducted on 112 ACS patients undergoing coronary stenting at Thong Nhat Dong Nai General Hospital. Results: The female-to-male ratio was 1.8:1, with a mean age of 67.14 ± 13.46 years, and the majority of patients were over 60 years old. The prevalence of overweight and obesity was 45.5%. Regarding lifestyle habits, 55.4% of patients were smokers, and 84.8% had a sedentary lifestyle. Among comorbidities, 84.8% had hypertension, and 28.6% had diabetes mellitus. The proportion of patients with non-HDL-C levels above 2.6 mmol/L was 76.8%. In the group with non-HDL-C >2.6 mmol/L, the number of affected coronary vessels was higher than in the group with non-HDL-C ≤2.6 mmol/L (3.42 ± 1.17 vs. 2.8 ± 1.18 vessels, 95% CI: 0.62 (0.1–1.14)), with a statistically significant difference (p = 0.02). Conclusion: The majority of ACS patients undergoing coronary stenting had elevated non-HDL-C levels. There was a statistically significant association between the number of affected coronary vessels and non-HDL-C levels in this patient population.
Article Details
Keywords
non-HDL cholesterol levels (non-HDL-C), coronary artery stenosis, acute coronary syndrome (ACS)
References
2. Lê Văn Duy, Hồ Anh Bình,Trần Quốc Bảo (2023), "Đánh giá thang điểm Risk-PCI trong dự báo biến cố tim mạch chính (mace) ở bệnh nhân hội chứng vành cấp được can thiệp động mạch vành qua da", Tạp Chí Y học lâm sàng Bệnh viện Trung Ương Huế, (89).
3. Trần Nguyễn Phương Hải, Hoàng Văn Sỹ (2024), "Giá trị tiên đoán kết cục tim mạch của non-high-density cholesterol ở bệnh nhân hội chứng mạch vành cấp không st chênh lên", Tạp chí Y học Việt Nam, 535 (1B).
4. Hội Tim mạch học Việt Nam. Khuyến cáo của Hội Tim mạch học Việt Nam về Quản lý hội chứng vành cấp, 2024.
5. Byrne R. A., Rossello X., Coughlan J., et al (2024), "2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)", European Heart Journal: Acute Cardiovascular Care, 13 (1), 55-161.
6. Catapano A., Ray K., Tokgozoglu S. Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future, 2022.
7. Haider S. S., Shahid M., Razaq K., et al (2022), "Association of Non HDL-Cholesterol and other lipid parameters in patients with Acute Coronary Syndrome", The Professional Medical Journal, 29 (01), 82-87.
8. Li C., He K., Yang Y., et al (2023), "Discordance of Circulating Non-HDL Cholesterol with LDL Cholesterol Concerning Long-Term Prognosis in Statin-Treated Individuals with Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting Undergoing Percutaneous Coronary Intervention", Reviews in Cardiovascular Medicine, 24 (9), 263.
9. Liu J., Zhao L., Zhang Y., et al (2024), "A higher non‐HDL‐C/HDL‐C ratio was associated with an increased risk of progression of nonculprit coronary lesion in patients with acute coronary syndrome undergoing percutaneous coronary intervention", Clinical Cardiology, 47 (2), e24243.
10. Mohammedi M. K. M., Altaweel R. B., Al Gburi A. K. K. (2024), "Exploring the Role of Non-HDL Cholesterol in Acute Coronary Syndrome: A Case-Control Study", Pakistan Heart Journal, 57 (1), 13-17.